Skip to main content
. 2023 Mar 29;15(7):2043. doi: 10.3390/cancers15072043

Table 2.

Chemical structure of dual pathway inhibitors.

Name Molecular Formula 2D Structure
Dactolisib C30H23N5O graphic file with name cancers-15-02043-i001.jpg
Gedatolisib C32H41N9O4 graphic file with name cancers-15-02043-i002.jpg
Voxtalisib C13H14N6O graphic file with name cancers-15-02043-i003.jpg
Bimiralisib C17H20F3N7O2 graphic file with name cancers-15-02043-i004.jpg
Paxalisib C18H22N8O2 graphic file with name cancers-15-02043-i005.jpg
Omipalisib C25H17F2N5O3S graphic file with name cancers-15-02043-i006.jpg
SF1126 C39H48N8O14 graphic file with name cancers-15-02043-i007.jpg
PF-04691502 C22H27N5O4 graphic file with name cancers-15-02043-i008.jpg
Samotolisib C22H27N5O4 graphic file with name cancers-15-02043-i009.jpg
Apitolisib C23H30N8O3S graphic file with name cancers-15-02043-i010.jpg
KPT-9274 C35H29F3N43 graphic file with name cancers-15-02043-i011.jpg

Figure source: PubChem®.